Product Code: ETC103183 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
India has experienced a tremendous growth in the demand for aerosol therapy devices due to rising prevalence of respiratory diseases and an increasing number of patients seeking medical care. The market for these devices is driven by factors such as growing awareness about the benefits associated with aerosol therapy, technological advances in nebulizer technologies, increased penetration of healthcare services and favourable reimbursement policies. Furthermore, various initiatives undertaken by the government of India to increase access to affordable healthcare are expected to further drive growth in this market over the forecast period.
The India Aerosol Therapy market is driven by increasing prevalence of chronic respiratory diseases, such as asthma and COPD, rising geriatric population base, and growing awareness about the therapeutic benefits associated with aerosol therapy. Additionally, the government initiatives to increase healthcare access in rural areas are expected to boost the market growth over the forecast period. Moreover, technological advancements in inhalation devices due to increased investments by leading players has enabled improved drug delivery among patients. Furthermore, introduction of patient compliance monitoring systems (PCM) which monitors usage patterns and provides feedback on medication adherence further increases accuracy for effective therapy management.
There are several challenges faced by stakeholders involved in this market such as high cost associated with advanced inhalers that restricts their adoption among low-income countries or regions; need for skilled professionals for operating these devices; lack of proper reimbursement policies; inadequate availability of training programs related to device handling; and limited patient compliance due to lack of motivation and awareness regarding disease conditions.
Major players operating in the India aerosol therapy market include Philips Healthcare, Smiths Medical CADD Prizm Inc., Omron Healthcare Inc., PARI GmbH, Becton Dickinson & Company (BD), Hamilton Medical AG, Resmed Corporation Inc., Aerogen Ltd., Invacare Corporation etc.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Aerosol therapy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Aerosol therapy Market Revenues & Volume, 2021 & 2031F |
3.3 India Aerosol therapy Market - Industry Life Cycle |
3.4 India Aerosol therapy Market - Porter's Five Forces |
3.5 India Aerosol therapy Market Revenues & Volume Share, By Product type, 2021 & 2031F |
3.6 India Aerosol therapy Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 India Aerosol therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 India Aerosol therapy Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 India Aerosol therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Aerosol therapy Market Trends |
6 India Aerosol therapy Market, By Types |
6.1 India Aerosol therapy Market, By Product type |
6.1.1 Overview and Analysis |
6.1.2 India Aerosol therapy Market Revenues & Volume, By Product type, 2018 - 2031F |
6.1.3 India Aerosol therapy Market Revenues & Volume, By Inhalers, 2018 - 2031F |
6.1.4 India Aerosol therapy Market Revenues & Volume, By Nebulizers, 2018 - 2031F |
6.2 India Aerosol therapy Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 India Aerosol therapy Market Revenues & Volume, By Manually operated, 2018 - 2031F |
6.2.3 India Aerosol therapy Market Revenues & Volume, By Digitally operated, 2018 - 2031F |
6.3 India Aerosol therapy Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 India Aerosol therapy Market Revenues & Volume, By Asthma, 2018 - 2031F |
6.3.3 India Aerosol therapy Market Revenues & Volume, By COPD, 2018 - 2031F |
6.3.4 India Aerosol therapy Market Revenues & Volume, By BPD, 2018 - 2031F |
6.3.5 India Aerosol therapy Market Revenues & Volume, By Other, 2018 - 2031F |
6.4 India Aerosol therapy Market, By End-users |
6.4.1 Overview and Analysis |
6.4.2 India Aerosol therapy Market Revenues & Volume, By Hospitals, 2018 - 2031F |
6.4.3 India Aerosol therapy Market Revenues & Volume, By Clinics, 2018 - 2031F |
6.4.4 India Aerosol therapy Market Revenues & Volume, By Ambulatory Surgical Centers, 2018 - 2031F |
6.4.5 India Aerosol therapy Market Revenues & Volume, By Individual, 2018 - 2031F |
7 India Aerosol therapy Market Import-Export Trade Statistics |
7.1 India Aerosol therapy Market Export to Major Countries |
7.2 India Aerosol therapy Market Imports from Major Countries |
8 India Aerosol therapy Market Key Performance Indicators |
9 India Aerosol therapy Market - Opportunity Assessment |
9.1 India Aerosol therapy Market Opportunity Assessment, By Product type, 2021 & 2031F |
9.2 India Aerosol therapy Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 India Aerosol therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 India Aerosol therapy Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 India Aerosol therapy Market - Competitive Landscape |
10.1 India Aerosol therapy Market Revenue Share, By Companies, 2024 |
10.2 India Aerosol therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |